Our News on Newswise

Newswise: 66c69467e0b01_salmonellaimage.JPG

Gut bioelectricity provides a path for bad bacteria to cause diseases

UC Davis Health researchers has discovered a novel bioelectrical mechanism pathogens like Salmonella use to find entry points in the gut lining that would allow them to pass and cause infection.
21-Aug-2024 9:05 PM EDT Add to Favorites

This news release is embargoed

Can naloxone improve survival rates of patients with cardiac arrest?

A new study from UC Davis Health assessed the link between naloxone administration by paramedics and the clinical outcomes for patients with out of hospital cardiac arrest.
16-Aug-2024 6:00 PM EDT Add to Favorites

UC Davis Health develops a real-time action plan to help patients with lung disease cope with wildfire smoke

A multidisciplinary team at UC Davis Health has developed an action plan to help patients with respiratory diseases mitigate the consequences of poor air quality from wildfires.
19-Aug-2024 2:05 PM EDT Add to Favorites

New brain-computer interface allows man with ALS to ‘speak’ again

A brain-computer interface developed by UC Davis Health accurately translates brain signals into speech. The device implanted in the brain of a man with ALS is the most accurate system of its kind.
14-Aug-2024 4:05 PM EDT Add to Favorites

Study shows donor kidneys with toxoplasma do not increase risks for transplant patients

Researchers determined that transplant patients who receive kidneys infected with the parasite toxoplasma have virtually the same outcomes as those who receive toxoplasma-negative organs.
8-Aug-2024 5:05 PM EDT Add to Favorites

UC Davis total-body advanced PET scanner EXPLORER can visualize dual blood supply in lung cancer

New study shows UC Davis total-body advanced PET scanner EXPLORER can visualize dual blood supply in lungs and effectively evaluate lung cancer and track treatment progress.
10-Jun-2024 3:05 PM EDT Add to Favorites

Treating nephrocalcinosis in newborns: A primer for clinicians

As many as 40% of preterm infants in the U.S. suffer from nephrocalcinosis, a condition that deposits excess calcium in kidneys.
10-Jun-2024 10:30 AM EDT Add to Favorites

Newswise: 6660e5241bf65_OvapreneandHand.png

Hormone-free barrier contraceptive undergoing clinical trial at UC Davis Health

The UC Davis Department of Obstetrics and Gynecology is recruiting potential participants for a clinical trial of an investigational hormone-free monthly intravaginal method of contraception.
6-Jun-2024 10:30 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Florette K. Gray Hazard appointed chair of Pathology and Laboratory Medicine

Florette K. Gray Hazard, a pediatric pathologist, has been appointed chair of the Department of Pathology and Laboratory Sciences at the UC Davis School of Medicine. She will lead a department with 50 faculty, 16 residents, and more than 400...
4-Mar-2024 6:05 PM EST

Are over-the-counter eye drops safe?

Dozens of eye drop recalls this year have left consumers confused about product safety. An expert explains why there have been so many recalls and how to pick safe eye drops.
19-Dec-2023 2:05 PM EST

Kids don't know they need glasses: 7 vision tips for parents

Can your child see the blackboard at school? Ophthalmologist Marcela Maria Estrada explains why kids often don’t know they have bad eyesight and gives tips for healthy vision.
18-Aug-2023 2:35 PM EDT

Anxiety disorders will affect nearly 1 in 3 adults: Here’s what you need to know

A UC Davis expert explains anxiety versus fear and how anxiety disorders can be effectively treated with therapy, medications and self-care.
10-May-2023 6:20 PM EDT

Extreme Risk Protection Orders to Prevent Mass Shootings: What Does the Research Show?

Mass shooters frequently share their plans, creating opportunities to intervene. Experts from the UC Davis Violence Prevention Research Program provide an overview of the research on mass shootings and the “red flag” laws or extreme risk...
24-Jun-2022 9:20 AM EDT

See All Experts

Our YouTube Videos

About

UC Davis Comprehensive Cancer Center is the only National Cancer Institute-designated center serving the Central Valley and inland Northern California, a region of more than 6 million people. Its specialists provide compassionate, comprehensive care for more than 100,000 adults and children every year and access to more than 200 active clinical trials at any given time. Its innovative research program engages more than 240 scientists at UC Davis who work collaboratively to advance discovery of new tools to diagnose and treat cancer. Patients have access to leading-edge care, including immunotherapy and other targeted treatments. Its Office of Community Outreach and Engagement addresses disparities in cancer outcomes across diverse populations, and the cancer center provides comprehensive education and workforce development programs for the next generation of clinicians and scientists.

Experts

Twitter

close
0.30055